Press Release

View printer-friendly version

<< Back

AMAG Pharmaceuticals to Present at Upcoming Investor Conferences

WALTHAM, Mass., March 05, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that management will participate in the following investor conferences during the month of March:

  • Cowen and Company 39th Annual Health Care Conference
    Monday, March 11, 2019 at 1:30 p.m. ET
    Location: Boston, MA

  • Barclays Global Healthcare Conference
    Wednesday, March 13, 2019 at 2:35 p.m. ET
    Location: Miami Beach, FL

  • Oppenheimer’s 29th Annual Healthcare Conference
    Tuesday, March 19, 2019 at 1:35 p.m. ET
    Location: New York, NY

A live audio webcast of each event will be accessible through the Investors section of the company’s website at www.amagpharma.com. A replay of each webcast will be archived on the company’s website for 30 days.

About AMAG
AMAG is a pharmaceutical company focused on bringing innovative products to patients with unmet medical needs. The company does this by leveraging its development and commercial expertise to invest in and grow its pharmaceutical products across a range of therapeutic areas, including women’s health. For additional company information, please visit www.amagpharma.com.

AMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc. 

AMAG Pharmaceuticals Contact:
Linda Lennox
908-627-3424

AMAG Pharmaceuticals logo

Source: AMAG Pharmaceuticals, Inc.